Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD®-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump. ECRI is an independent non-profit organisation improving the safety, quality and cost-effectiveness of care across all healthcare settings worldwide (www.ecri.org). The report highlights ECRI’s evaluation ratings, test results and purchasing recommendations for the CADD®-Solis pump.
The CADD®-Solis v4 system is a continuation of Smiths Medical’s commitment to advance patient care and help improve patient outcomes through leading-edge technology.
The CADD®-Solis pump maintains the advantages of an ambulatory pump for patient mobility and provides a single system that effectively delivers IV PCA, epidural, peripheral nerve blocks and subcutaneous from pump to patient. For the hospital, the CADD®-Solis system is designed to enhance patient safety through ‘smart programming’ (use of medication safety software) and reduce the risk of tubing misconnections, while providing a comprehensive and intuitive user experience for the healthcare provider.
Glen Johnson, NordUK Senior Marketing Manager at Smiths Medical, says: “Smiths Medical is committed to patient safety and adoption of smart infusion pumps. The wireless bi-directional communication sets the foundation for 
integrating pain management data delivery directly into the patient records in a hospital’s Electronic Health Records (EHR auto-documentation), saving clinicians time charting and increasing documentation accuracy.”
For more information about the CADD®-Solis PCA and epidural pump, or for a copy of the report, contact Glen Johnson, NordUK Senior Marketing Manager at Smiths Medical, on 01233 722 100, email [email protected] or visit www.smiths-medical.com/CADD-Solis-Infusion-System.
